JP2020529194A5 - - Google Patents

Download PDF

Info

Publication number
JP2020529194A5
JP2020529194A5 JP2019571025A JP2019571025A JP2020529194A5 JP 2020529194 A5 JP2020529194 A5 JP 2020529194A5 JP 2019571025 A JP2019571025 A JP 2019571025A JP 2019571025 A JP2019571025 A JP 2019571025A JP 2020529194 A5 JP2020529194 A5 JP 2020529194A5
Authority
JP
Japan
Prior art keywords
dna
amount
total
subject
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019571025A
Other languages
English (en)
Japanese (ja)
Other versions
JP7323462B2 (ja
JP2020529194A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/038609 external-priority patent/WO2018237081A1/en
Publication of JP2020529194A publication Critical patent/JP2020529194A/ja
Publication of JP2020529194A5 publication Critical patent/JP2020529194A5/ja
Application granted granted Critical
Publication of JP7323462B2 publication Critical patent/JP7323462B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019571025A 2017-06-20 2018-06-20 セルフリーdnaによる移植患者のモニタリング Active JP7323462B2 (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201762522570P 2017-06-20 2017-06-20
US62/522,570 2017-06-20
US201762576631P 2017-10-24 2017-10-24
US62/576,631 2017-10-24
US201862653213P 2018-04-05 2018-04-05
US201862653517P 2018-04-05 2018-04-05
US62/653,517 2018-04-05
US62/653,213 2018-04-05
US201862655030P 2018-04-09 2018-04-09
US62/655,030 2018-04-09
PCT/US2018/038609 WO2018237081A1 (en) 2017-06-20 2018-06-20 PATIENT MONITOR TRANSPLANT WITH ACELLULAR DNA

Publications (3)

Publication Number Publication Date
JP2020529194A JP2020529194A (ja) 2020-10-08
JP2020529194A5 true JP2020529194A5 (cg-RX-API-DMAC7.html) 2021-07-29
JP7323462B2 JP7323462B2 (ja) 2023-08-08

Family

ID=64737312

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019571025A Active JP7323462B2 (ja) 2017-06-20 2018-06-20 セルフリーdnaによる移植患者のモニタリング

Country Status (8)

Country Link
US (1) US20210139983A1 (cg-RX-API-DMAC7.html)
EP (1) EP3642356A4 (cg-RX-API-DMAC7.html)
JP (1) JP7323462B2 (cg-RX-API-DMAC7.html)
CN (1) CN110945144A (cg-RX-API-DMAC7.html)
AU (1) AU2018288838A1 (cg-RX-API-DMAC7.html)
CA (1) CA3067635A1 (cg-RX-API-DMAC7.html)
IL (1) IL271459A (cg-RX-API-DMAC7.html)
WO (1) WO2018237081A1 (cg-RX-API-DMAC7.html)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
EP2854058A3 (en) 2010-05-18 2015-10-28 Natera, Inc. Methods for non-invasive pre-natal ploidy calling
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US12655483B2 (en) 2010-05-18 2026-06-16 Natera, Inc. Methods for simultaneous amplification of target loci
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
AU2011348100B2 (en) 2010-12-22 2016-08-25 Natera, Inc. Methods for non-invasive prenatal paternity testing
JP6153874B2 (ja) 2011-02-09 2017-06-28 ナテラ, インコーポレイテッド 非侵襲的出生前倍数性呼び出しのための方法
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
PL3117012T5 (pl) 2014-03-14 2026-03-16 Caredx, Inc. Sposoby monitorowania terapii immunosupresyjnych u biorcy przeszczepu
RU2717641C2 (ru) 2014-04-21 2020-03-24 Натера, Инк. Обнаружение мутаций и плоидности в хромосомных сегментах
US20180173845A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
EP4428863A3 (en) 2015-05-11 2024-12-11 Natera, Inc. Methods and compositions for determining ploidy
JP7280044B2 (ja) 2016-04-15 2023-05-23 ナテラ, インコーポレイテッド 肺癌の検出方法
WO2018067517A1 (en) 2016-10-04 2018-04-12 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
CN110945136A (zh) 2017-06-20 2020-03-31 威斯康星州立大学医学院 使用总无细胞dna评估移植并发症风险
WO2019118926A1 (en) 2017-12-14 2019-06-20 Tai Diagnostics, Inc. Assessing graft suitability for transplantation
EP3737773B1 (en) 2018-01-12 2023-04-12 Natera, Inc. Novel primers and uses thereof
DK3781714T3 (da) 2018-04-14 2026-03-30 Natera Inc Fremgangsmåder til cancerpåvisning og -overvågning ved personlig påvisning af cirkulerende tumor-dna
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
EP3847280A1 (en) 2018-09-07 2021-07-14 Sequenom, Inc. Methods, and systems to detect transplant rejection
US20220093208A1 (en) * 2019-02-19 2022-03-24 Sequenom, Inc. Compositions, methods, and systems to detect hematopoietic stem cell transplantation status
CA3135853A1 (en) * 2019-04-03 2020-10-08 The Medical College Of Wisconsin, Inc. Transplant patient monitoring with cell-free dna
US11931674B2 (en) 2019-04-04 2024-03-19 Natera, Inc. Materials and methods for processing blood samples
US12305235B2 (en) 2019-06-06 2025-05-20 Natera, Inc. Methods for detecting immune cell DNA and monitoring immune system
WO2022015676A1 (en) * 2020-07-13 2022-01-20 The Medical College Of Wisconsin, Inc. Methods for making treatment management decisions in transplant subjects and assessing transplant risks with threshold values

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2496720T3 (da) * 2009-11-06 2020-09-28 Univ Leland Stanford Junior Ikke-invasiv diagnose af transplantatafstødning i organ-transplanterede patienter
CN102892901B (zh) 2010-03-24 2015-11-25 凸版印刷株式会社 利用竞争性引物的目标碱基序列的检测方法
US20130123120A1 (en) * 2010-05-18 2013-05-16 Natera, Inc. Highly Multiplex PCR Methods and Compositions
US10385396B2 (en) 2012-04-19 2019-08-20 The Medical College Of Wisconsin, Inc. Highly sensitive surveillance using detection of cell free DNA
HK1217733A1 (zh) * 2013-03-15 2017-01-20 Immucor Gti Diagnostics, Inc. 使用尿游离dna评估肾状态的方法和组合物
PL3004388T5 (pl) * 2013-05-29 2023-10-09 Chronix Biomedical Wykrywanie i oznaczanie ilościowe pozakomórkowego dna dawcy w układzie krążenia biorców przeszczepów organów
WO2015058194A1 (en) * 2013-10-18 2015-04-23 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Allele specific pcr assay for detection of nucleotide variants
PL3117012T5 (pl) * 2014-03-14 2026-03-16 Caredx, Inc. Sposoby monitorowania terapii immunosupresyjnych u biorcy przeszczepu
AU2016255573A1 (en) * 2015-04-30 2017-12-21 The Medical College Of Wisconsin, Inc. Multiplexed optimized mismatch amplification (MOMA)-real time PCR for assessing cell-free DNA

Similar Documents

Publication Publication Date Title
JP2020524519A5 (cg-RX-API-DMAC7.html)
JP7323462B2 (ja) セルフリーdnaによる移植患者のモニタリング
JP2019534017A5 (cg-RX-API-DMAC7.html)
JP2022002508A5 (cg-RX-API-DMAC7.html)
US20210139988A1 (en) Assessing conditions in transplant subjects using donor-specific cell-free dna
JP2022526984A (ja) 無細胞dnaでの移植患者の監視
US20220340963A1 (en) Methods for assessing graft suitability for transplantation
JP2022180384A5 (cg-RX-API-DMAC7.html)
JP2020529193A5 (cg-RX-API-DMAC7.html)
JP2022002508A (ja) 無細胞dnaを評価するための多重/最適化ミスマッチ増幅(moma)−リアルタイムpcr
US10683538B2 (en) Quality assessment of circulating cell-free DNA using multiplexed droplet digital PCR
US8741557B2 (en) Predicting graft rejection
US20180346982A1 (en) Detection and quantification of donor cell-free dna in the circulation of organ transplant recipients
JP2018514219A5 (cg-RX-API-DMAC7.html)
JP2019514387A5 (cg-RX-API-DMAC7.html)
JP2020524519A (ja) 全セルフリーdnaによる移植合併症リスクの評価
WO2020206292A2 (en) Assessing conditions in transplant subjects using donor-specific cell-free dna
JP2019518438A5 (cg-RX-API-DMAC7.html)
JP2019518437A5 (cg-RX-API-DMAC7.html)
Pirog et al. Standardization of a High‐Quality Methodological Framework for Long‐Term Genetic Monitoring of the French Wolf Population
EP3181699A1 (en) Micrornas as predictive biomarkers of type 1 diabetes
TWI615472B (zh) 預測乳癌復發之基因標記及方法
CN111518896A (zh) 用于检测尼古丁依赖相关的snp位点的引物组、应用、产品及方法
Hausknecht et al. Application of quantitative real‐time polymerase chain reaction for noninvasive genetic monitoring
Turki et al. ¬ Relationship of ACTN3-Promoter gene polymorphism and Alpha actin-3 concentration with performance of Original Arabian-WAHO horses